Contact
searchSearch
HMP Global

Volume 28 - Issue 10 - October, 2016

Feature

Original Contribution
Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation
10/20/2016
Aortic valve preparation with balloon aortic valvuloplasty (BAV) has been previously considered mandatory during TAVIs. BAV-inherent risks including stroke, conduction abnormalities, and reduced device profile size established the rationale...
Aortic valve preparation with balloon aortic valvuloplasty (BAV) has been previously considered mandatory during TAVIs. BAV-inherent risks including stroke, conduction abnormalities, and reduced device profile size established the rationale...
Aortic valve preparation with...
10/20/2016
Journal of Invasive Cardiology
Original Contribution
Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry
10/01/2016
We sought to determine the impact of proximal cap ambiguity on procedural techniques and outcomes for coronary chronic total occlusion percutaneous coronary intervention.
We sought to determine the impact of proximal cap ambiguity on procedural techniques and outcomes for coronary chronic total occlusion percutaneous coronary intervention.
We sought to determine the...
10/01/2016
Journal of Invasive Cardiology
Original Contribution
Influence of Human Immunodeficiency Virus Seropositive Status on the In-Hospital Management and Outcomes of Patients Presenting With Acute Myocardial Infarction
10/01/2016
Human immunodeficiency virus (HIV) seropositive individuals are predisposed to acute myocardial infarction (AMI). We sought to evaluate management strategies and outcomes of AMI in patients with HIV in the contemporary era.
Human immunodeficiency virus (HIV) seropositive individuals are predisposed to acute myocardial infarction (AMI). We sought to evaluate management strategies and outcomes of AMI in patients with HIV in the contemporary era.
Human immunodeficiency virus...
10/01/2016
Journal of Invasive Cardiology
Original Contribution
Comparison of Percutaneous Closure Versus Surgical Femoral Cutdown for Decannulation of Large-Sized Arterial and Venous Access Sites in Adults After Successful Weaning of Veno-Arterial Extracorporeal Membrane Oxygenation
10/01/2016
Surgical femoral cutdown for decannulation after veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is considered standard practice. However, access-site complications with this technique are not rare. The objective of this study is...
Surgical femoral cutdown for decannulation after veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is considered standard practice. However, access-site complications with this technique are not rare. The objective of this study is...
Surgical femoral cutdown for...
10/01/2016
Journal of Invasive Cardiology
Clinical Images
Cocaine-Induced Microvascular Dysfunction and its Reversal by Administration of Intracoronary Calcium-Channel Blocker
10/01/2016
A 47-year-old male smoker with recent cocaine use presented with 6 hours of chest pain unrelieved by sublingual and intravenous nitroglycerin. To our knowledge, this is the first reported case demonstrating the efficacy of an intracoronary...
A 47-year-old male smoker with recent cocaine use presented with 6 hours of chest pain unrelieved by sublingual and intravenous nitroglycerin. To our knowledge, this is the first reported case demonstrating the efficacy of an intracoronary...
A 47-year-old male smoker with...
10/01/2016
Journal of Invasive Cardiology
Clinical Images
The Absorb Limits
10/01/2016
A patient presented with an inferior non-ST segment elevation myocardial infarction and a tight lesion on the distal right coronary artery. After stent implantation, a large scaffold malapposition was observed by optical coherence tomography....
A patient presented with an inferior non-ST segment elevation myocardial infarction and a tight lesion on the distal right coronary artery. After stent implantation, a large scaffold malapposition was observed by optical coherence tomography....
A patient presented with an...
10/01/2016
Journal of Invasive Cardiology
Clinical Images
Arterial Discordance in Cardiac Tamponade
10/01/2016
Ventricular interdependence is a salient hemodynamic feature of cardiac tamponade that manifests as discordance between the left and right ventricles in filling and ejection on hemodynamic assessment. Ventricular interdependence can manifest...
Ventricular interdependence is a salient hemodynamic feature of cardiac tamponade that manifests as discordance between the left and right ventricles in filling and ejection on hemodynamic assessment. Ventricular interdependence can manifest...
Ventricular interdependence is a...
10/01/2016
Journal of Invasive Cardiology
Original Contribution
Pericardiocentesis Under Continuous Ultrasonographic Guidance Using a 7 cm Micropuncture Needle
08/15/2016
A comparison of procedural success and safety of pericardiocentesis using continuous ultrasonographic visualization of a long (7 cm) micropuncture needle to standard access with an 18 gauge needle without continuous ultrasound guidance.
A comparison of procedural success and safety of pericardiocentesis using continuous ultrasonographic visualization of a long (7 cm) micropuncture needle to standard access with an 18 gauge needle without continuous ultrasound guidance.
A comparison of procedural...
08/15/2016
Journal of Invasive Cardiology

Insights

Commentary
Balloon Predilation for TAVR: Over-Inflated or Under-Rated?
10/01/2016
This commentary discusses several isues that arise from this month's article by Abramowitz et al and offers further insights into the ongoing discussion of the need for predilation during TAVR.
This commentary discusses several isues that arise from this month's article by Abramowitz et al and offers further insights into the ongoing discussion of the need for predilation during TAVR.
This commentary discusses...
10/01/2016
Journal of Invasive Cardiology

Department

Letters to the Editor
Contrast Dose, Estimated GFR, and Techniques to Reduce Contrast Dose in PCI – Time to Consider Some Basic Principles!
09/27/2016
A commentary on Gurm et al (JIC April 2016). Dr Nyman addresses the issue of the formula used by the investigators to establish creatinine clearance, and the potential effects of this choice on their study results.
A commentary on Gurm et al (JIC April 2016). Dr Nyman addresses the issue of the formula used by the investigators to establish creatinine clearance, and the potential effects of this choice on their study results.
A commentary on Gurm et al (JIC...
09/27/2016
Journal of Invasive Cardiology

News

AHA Scientific Statement
New American Heart Association Scientific Statement on Pulmonary Embolism Management & Outcomes
03/21/2025
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from...
03/21/2025
Cath Lab Digest
Therapeutics
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
03/21/2025
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the...
03/21/2025
Cath Lab Digest
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
SCAI
JSCAI Special Issue Explores the Transformative Role of Artificial Intelligence in Interventional Cardiology
03/18/2025
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of...
03/18/2025
Cath Lab Digest
Acquisitions
Ostial Corporation Becomes Verge Medical Following Strategic Acquisition
03/17/2025
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on...
03/17/2025
Cath Lab Digest
AltiX AI.i ComboLab
AI
GE HealthCare Expands Invasive Cardiology Portfolio With AltiX AI.i for Cath Lab and EP Procedures 
03/17/2025
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are...
03/17/2025
Cath Lab Digest
Heart Formation
New Hope for Heart Disease: Unlocking How the Heart Forms Before Birth
03/17/2025
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's...
03/17/2025
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
ESC: Resuscitation in Out-of-Hospital Cardiac Arrest – It’s How Quickly It Is Done, Rather Than Who Does It
03/17/2025
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of...
03/17/2025
Cath Lab Digest
Heart Failure
U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%
03/17/2025
KERENDIA® (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular (CV) endpoint in a Phase III study investigating patients with heart failure (HF) with mildly reduced...
KERENDIA® (finerenone) is the first non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA) to meet a primary cardiovascular (CV) endpoint in a Phase III study investigating patients with heart failure (HF) with mildly reduced...
KERENDIA® (finerenone) is the...
03/17/2025
Cath Lab Digest
CAD Diagnosis: AI
Caristo Diagnostics Receives U.S. FDA 510(k) Clearance of CaRi-Plaque Technology, an AI-assisted Image Analysis Application to Aid the Diagnosis of Coronary Artery Disease (CAD)
03/13/2025
CaRi-Plaque builds on Caristo’s breakthrough core CaRi-Heart® technology, which a landmark Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression — predicting heart attacks up to a decade before they strike.
CaRi-Plaque builds on Caristo’s breakthrough core CaRi-Heart® technology, which a landmark Lancet 2024 study proved can reveal hidden, high-risk markers of CAD progression — predicting heart attacks up to a decade before they strike.
CaRi-Plaque builds on Caristo’s...
03/13/2025
Cath Lab Digest

Endologix Announces 1000 Patients Treated With the DETOUR System
03/21/2025
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to percutaneously bypass lesions in the superficial femoral artery by using stents routed through the...
Percutaneous Transmural Arterial Bypass (PTAB) with the DETOUR System offers a novel approach to treating complex PAD, enabling physicians to percutaneously bypass lesions in the superficial femoral artery by using stents routed through the...
Percutaneous Transmural Arterial...
03/21/2025
Cath Lab Digest
AHA Scientific Statement
New American Heart Association Scientific Statement on Pulmonary Embolism Management & Outcomes
03/21/2025
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from the American Heart Association, Disparities in Current Pulmonary Embolism Management and Outcomes, summarizes differences in diagnosis, treatment strategies and long-term outcomes related to PE.
A new scientific statement from...
03/21/2025
Cath Lab Digest
Therapeutics
Alnylam Announces FDA Approval of Amvuttra (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM)
03/21/2025
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the indication for AMVUTTRA, which now becomes the first and only therapeutic approved by the FDA for the treatment of ATTR-CM and the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.
The approval expands the...
03/21/2025
Cath Lab Digest
TAVR
Medtronic’s Evolut Trial Outcome Could Shake Up US TAVR Market, Says GlobalData
03/21/2025
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results from the two-year point of a clinical trial comparing its Evolut to Edwards Lifesciences’ SAPIEN. The results revealed that the Evolut showed superior performance to the SAPIEN. Specifically, the Evolut showed...
Medtronic has released results...
03/21/2025
Vascular Disease Management
SCAI
JSCAI Special Issue Explores the Transformative Role of Artificial Intelligence in Interventional Cardiology
03/18/2025
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of our daily lives, whether we are prepared for it or not. In medicine, particularly in interventional cardiology, its impact is profound,” said guest editor Elazer R. Edelman, MD, PhD.
"AI is now an integral part of...
03/18/2025
Cath Lab Digest
ES image
CRT Conference Coverage
Future Direction for RDN: From Hypertension to AFib and Beyond
03/18/2025
In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment.
In this video from CRT 2025, JIC speaks with Dr Eric Secemsky of the Beth Israel Deaconness Medical Center about the future of renal denervation in atrial fibrillation treatment.
In this video from CRT 2025, JIC...
03/18/2025
Journal of Invasive Cardiology
Acquisitions
Ostial Corporation Becomes Verge Medical Following Strategic Acquisition
03/17/2025
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on addressing the clinical challenges of aorto-ostial interventions, announced the acquisition of the Wavella™ technology from Crossfire Medical. The company also unveiled its new identity as Verge Medical.
Ostial Corporation, focused on...
03/17/2025
Cath Lab Digest
AltiX AI.i ComboLab
AI
GE HealthCare Expands Invasive Cardiology Portfolio With AltiX AI.i for Cath Lab and EP Procedures 
03/17/2025
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features...
The AltiX AI.i editions are...
03/17/2025
Cath Lab Digest
Heart Formation
New Hope for Heart Disease: Unlocking How the Heart Forms Before Birth
03/17/2025
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's findings, published in Science, focus on long, thin, channels of membranes – called Tunneling Nanotube-Like Structures - that connect cells together.
Dr. Mingfu Wu and his team's...
03/17/2025
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
ESC: Resuscitation in Out-of-Hospital Cardiac Arrest – It’s How Quickly It Is Done, Rather Than Who Does It
03/17/2025
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of out-of-hospital cardiac arrests (OHCA) occur in residential settings highlights the crucial need for further public education and Basic Life Support (BLS) training to improve survival rates.
The fact that 80% of...
03/17/2025
Cath Lab Digest

October 2016 Volume 28 Issue 10

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use